Edition:
United Kingdom

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

22.77USD
7:55pm BST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$22.77
Open
$22.75
Day's High
$23.30
Day's Low
$22.43
Volume
162,273
Avg. Vol
228,349
52-wk High
$36.12
52-wk Low
$16.97

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 0.00 -1.009
Mar '19 0.00 -0.875
FY 2018 Dec '18 0.00 -0.953
Sep '18 0.00 -0.887
Jun '18 0.00 -0.908
Mar '18 0.00 -0.924
FY 2017 Dec '17 0.00 -0.281
Sep '17 0.00 -0.630
Jun '17 0.00 -0.647
Mar '17 0.00 -0.517
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 9 0.00 0.00 0.00 10.05
Quarter Ending Dec-19 9 0.00 0.00 0.00 15.23
Year Ending Dec-19 9 0.00 0.00 0.00 24.76
Year Ending Dec-20 10 55.17 74.55 35.00 189.96
Earnings (per share)
Quarter Ending Sep-19 10 -1.04 -0.88 -1.12 -0.88
Quarter Ending Dec-19 10 -1.08 -0.92 -1.27 -0.80
Year Ending Dec-19 10 -4.02 -3.68 -4.26 -3.33
Year Ending Dec-20 10 -3.59 -2.75 -4.11 -1.28
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.39 32.66
P/E High - Last 5 Yrs. -- 147.53 47.31
P/E Low - Last 5 Yrs. -- 47.83 23.88
Beta -- 1.08 0.89
Price to Sales (TTM) -- 49.44 7.91
Price to Book (MRQ) 5.40 10.14 5.38
Price to Tangible Book (MRQ) 5.41 13.75 6.71
Price to Cash Flow (TTM) -- 55.95 24.36
% Owned Institutions 85.47 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.01 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.58 12.23
Sales (TTM) vs TTM 1 Yr. Ago -- 49.07 7.74
Sales - 5 Yr. Growth Rate -- 22.80 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -49.09 76.36 42.97
EPS (TTM) vs TTM 1 Yr. Ago -44.88 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.31
Capital Spending - 5 Yr. Growth Rate -- 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 13.45 3.59 3.03
LT Debt to Equity (MRQ) 0.00 18.57 10.20
Total Debt to Equity (MRQ) 0.00 31.19 14.55
Interest Coverage (TTM) -- -44.62 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.09 52.24
Gross Margin - 5 Yr. Avg. -- 60.28 50.41
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.44 13.12
Operating Margin (TTM) -- -183.66 6.81
Operating Margin - 5 Yr. Avg. -- -126.87 8.92
Pre-Tax Margin (TTM) -- -174.35 5.99
Pre-Tax Margin - 5 Yr. Avg. -- -132.63 9.22
Net Profit Margin (TTM) -- -181.04 2.63
Net Profit Margin - 5 Yr. Avg. -- -137.00 5.58
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,668,680 887,291,376
Net Income/Employee (TTM) -1,529,406 533,005 101,845,050
Receivable Turnover (TTM) -- 6.23 5.93
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) 0.00 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.75 6.40 11.17
Return on Assets - 5 Yr. Avg. -- 5.50 12.34
Return on Investment (TTM) -50.47 8.95 14.48
Return on Investment - 5 Yr. Avg. -- 6.82 16.02
Return on Equity (TTM) -50.82 10.09 15.78
Return on Equity - 5 Yr. Avg. -- 8.46 17.01
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -0.51 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aimmune Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.22 5.45 99 98
13 Week 22.10 16.15 99 95
26 Week 26.67 17.04 99 97
52 Week 53.60 30.19 99 71
YTD 24.01 8.91 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 87.81%
# of Holders: 190
Total Shares Held: 55,032,590
3 Mo. Net Change: 1,439,278
# New Positions: 29
# Closed Positions: 20
# Increased Positions: 93
# Reduced Positions: 70
# Net Buyers: 23
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.